In several cases such as India, Singapore, Spain, Portugal, Italy and Malaysia, their assessments around compliance with Recommendation 15 are ongoing so the table rated them as N/A (not applicable). Other nations, such as Argentina, had conducted a risk assessment covering VASPs but had not completed any of the other seven relevant criteria.